Expressions of E-cadherin, Cortactin and MMP-9 in Pseudoepitheliomatous Hyperplasia and Squamous Cell Carcinoma of the Head and Neck: Their Relationships with Clinicopathologic Factors and Prognostic Implication

다국어 초록 (Multilingual Abstract)

Background: E-cadherin, cortactin, and matrix metalloproteinase (MMP)-9 have roles in tumor development or progression, but their expression has not been fully investigated in pseudoepitheliomatous hyperplasia (PEH) and squamous cell carcinoma (SCC) of the head and neck. Methods: We evaluated the immunohistochemical expression of E-cadherin, cortactin, and MMP-9 in 29 cases of PEH and 97 cases of SCC. Additionally, we evaluated their relationship with clinicopathologic factors and prognostic implications in SCC. Results: Thirty-five cases of SCC showed reduced expression of E-cadherin, whereas none of the PEH did. A total of 20 cases and 11 cases of SCC were immunoreactive for cortactin and MMP-9, respectively, whereas none of the PEH did. In SCC, reduced expression of E-cadherin was correlated with cortactin expression and invasion depth. Cortactin expression was correlated with differentiation, T classification, and recurrence and/or metastasis. MMP-9 expression was correlated with invasion depth. Cortactin expression was correlated with poor overall survival and relapse-free survival and it was an independent prognostic factor. Conclusions: The reduced expression of E-cadherin and the expression of cortactin may be helpful for the differential diagnosis of PEH and SCC. Furthermore, cortactin expression in association with reduced E-cadherin expression is correlated with poor prognosis in SCC.

참고문헌 (Reference)

1 Lee YS, "p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin" 73 : 2317-2323, 1994

2 Barnes L, "World Health Organization classification of tumours: pathology and genetics of head and neck tumours" IARC Press 2005

3 Yeh KT, "The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma" 22 : 3971-3975, 2002

4 Ruokolainen H, "Serum matrix metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker" 116 : 422-427, 2005

5 Mira E, "Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface" 117 (117): 1847-1857, 2004

6 Mitra RS, "Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma" 68 : 3959-3969, 2008

7 Chuma M, "Overexpression of cortactinis involved in motility and metastasis of hepatocellular carcinoma" 41 : 629-636, 2004

8 Yamada S, "Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma" 16 : 523-531, 2010

9 Egeblad M, "New functions for the matrix metalloproteinases in cancer progression" 2 : 161-174, 2002

10 Ohashi K, "Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas" 88 : 2201-2209, 2000

11 Grandis JR, "Head and neck cancer: meeting summary and research opportunities" 64 : 8126-8129, 2004

12 Ruokolainen H, "Expression of matrix metalloproteinase-9 in head and neck squamous cell carcinoma: a potential marker for prognosis" 10 : 3110-3116, 2004

13 Franchi A, "Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck" 95 : 1902-1910, 2002

14 Impola U, "Expression of matrix metalloproteinase (MMP)-7 and MMP-13 and loss of MMP-19 and p16 are associated with malignant progression in chronic wounds" 152 : 720-726, 2005

15 Riedel F, "Expression of 92-kDa type IV collagenase correlates with angiogenic markers and poor survival in head and neck squamous cell carcinoma" 17 : 1099-1105, 2000

16 Rodrigo JP, "EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck" 6 : 3177-3182, 2000

17 Kyzas PA, "Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance" 30 : 185-193, 2006

18 Zarovnaya E, "Distinguishing pseudoepitheliomatous hyperplasia from squamous cell carcinoma in mucosal biopsy specimens from the head and neck" 129 : 1032-1036, 2005

19 Kurtz KA, "Decreased immunohistochemical expression of E-cadherin but not B-catenin is associated with increased risk of vascular invasion and decreased survival in head and neck squamous cell carcinomas" 85 (85): 214-, 2005

20 Weed SA, "Cortactin: coupling membrane dynamics to cortical actin assembly" 20 : 6418-6434, 2001

21 Li Y, "Cortactin potentiates bone metastasis of breast cancer cells" 61 : 6906-6911, 2001

22 Hsu NY, "Cortactin overexpression in the esophageal squamous cell carcinoma and its involvement in the carcinogenesis" 21 : 402-408, 2008

23 Helwani FM, "Cortactin is necessary for E-cadherin-mediated contact formation and actin reorganization" 164 : 899-910, 2004

24 Clark ES, "Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia" 67 : 4227-4235, 2007

25 Geramizadeh B, "Comparison of proliferative (Ki67) and cell adhesion (E-cadherin) markers between gastric intestinal metaplasia and Barrett’s esophagus" 28 : 115-116, 2009

26 Williams ME, "Chromosome 11Q13 amplification in head and neck squamous cell carcinoma" 119 : 1238-1243, 1993

27 Sagi A, "Atypical pseudoepitheliomatous hyperplasia in squamous cell carcinoma in chronic wounds" 74 : 315-316, 1984

28 Luo ML, "Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance" 66 : 11690-11699, 2006

29 Li X, "Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas" 33 : 69-79, 2008

30 Edge SB, "AJCC cancer staging manual. 7th ed" Springer 2010